Krystal Biotech (KRYS) was granted FDA orphan designation for its treatment of Hailey-Hailey disease, according to a post to the agency’s website. Published first on TheFly – the ultimate source for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback